Company Filing History:
10 out of 972 
2 out of 1,245 
Years Active: 2016-2025
Title: The Innovative Contributions of Inventor Minying Cai
Introduction: Minying Cai, an accomplished inventor based in Tucson, AZ, has made significant strides in the field of biomedical sciences. With a portfolio of nine patents, her work primarily focuses on the development of novel therapeutics for the treatment of depression and anxiety disorders. Her innovative approaches leverage the modulation of melanocortin receptors, which have the potential to improve psychiatric health significantly.
Latest Patents: Two of Cai's noteworthy patents include the development of modulators of melanocortin receptors specifically for the treatment of depression and anxiety. The first patent describes compositions and methods that deliver a therapeutically effective amount of a composition containing a melanocortin 5 receptor (MC5R) peptide ligand within a pharmaceutically acceptable carrier. This method notably demonstrates clinical improvement in subjects within a relatively short timeframe. The second patent addresses the modulators of melanocortin receptors, providing a sophisticated formula that outlines the characteristics and variations of the MC5R peptide ligand. This innovation opens potential pathways for creating more effective treatments targeting mood disorders through a deeper understanding of peptide interactions.
Career Highlights: Minying Cai has held esteemed positions at prominent academic institutions, including the University of Arizona and The Texas A&M University System. Her work at these institutions has allowed her to collaborate on groundbreaking research aimed at enhancing mental health therapies through innovative peptide design and therapeutic applications.
Collaborations: Throughout her career, Cai has collaborated with notable scientists and researchers, including Victor J. Hruby and Horst Kessler. These collaborations have facilitated significant advancements in the understanding and application of melanocortin receptor modulation, evidencing the importance of teamwork in the scientific community.
Conclusion: Minying Cai stands out as a pioneer in the field of medicine, particularly in the domain of psychiatric treatment innovations. Her extensive patent portfolio reflects her commitment to improving the lives of individuals dealing with anxiety and depression. As researchers continue to explore the potential of melanocortin receptors, Cai's contributions will undoubtedly play a crucial role in shaping future therapeutic strategies.